AFLAC Incorporated (AFL) Earnings Call Analysis

NYSE · Financial Services · Insurance - Life

22/25

Growth 4 Margin 4 Expansion 5 Platform 4 Financial 5

latest quarter score

Earnings Reports

22
AFLAC (AFL) Q2 2026: Japan Sales Exceed Prior Year Amid Strategic Reinsurance Expansion
August 08, 2026
19
Aflac (AFL) Q4 2025: $4.8B Capital Return Underscores Persistent Margin Discipline Amid Japan Sales Surge
June 15, 2026
18
Aflac (AFL) Q1 2026: Japan Sales Jump 25% as Distribution and Product Mix Drive Margin Upside
April 30, 2026
22
Aflac (AFL) Q3 2025: $1B Buybacks Signal Capital Flexibility as Japan Cancer Sales Jump 42%
November 05, 2025
18
Aflac (AFL) Q2 2025: Japan Cancer Sales Surge 53%, Driving Channel Revitalization
August 06, 2025
21
AFLAC (AFL) Q1 2025: $900M Buyback Underscores Capital Flexibility Amid Japan Product Pivot
June 30, 2025
Aflac (AFL) Q3 2024: Sumitas Drives 12% Japan Sales Growth, Signals Product-Led Diversification
October 31, 2024
AFLAC (AFL) Q2 2024: Sumitas Launch Lifts Japan Sales 4.5%, Underpins Cross-Sell Strategy
August 01, 2024
Aflac (AFL) Q1 2024: Japan Margin Expands 460bps as Distribution Mix Shifts
May 02, 2024
AFLAC (AFL) Q4 2023: $2.8B Buybacks and Expense Ratio Shift Signal Capital Deployment Discipline
February 01, 2024
24
Aflac (AFL) Q3 2023: Japan Cancer Sales Jump 23% as Capital Deployment Strengthens Shareholder Returns
November 02, 2023
Aflac (AFL) Q2 2023: Japan Cancer Sales Jump 60% as Product Refresh Powers Distribution Momentum
August 02, 2023
Aflac (AFL) Q1 2023: $500M CRE Foreclosure Risk Highlights Capital Resilience Amid Product Expansion
April 27, 2023

Browse all companies